Latest News Archive
Please select Category, Year, and then Month to display items
29 March 2021
|
Story Lacea Loader
![]()
1. Its support of and confidence in the leadership of the Rector and Vice-Chancellor of the UFS, Prof Francis Petersen and his team, and duly recognises the efforts and results achieved at the University during the challenges posed by the COVID-19 pandemic, as well as the current nationwide student protest on the payment of student debt.
2. In this context, the Council also distances itself and deplores the statements made by the leadership of the
Institutional Student Representative Council (ISRC), on national television on Monday 15 March 2021, as it pertained to the demand for the immediate resignation of the Rector and Vice-Chancellor, and the statements pertaining to the Chancellor, Prof Bonang Mohale, and Chairperson of the Council, Dr Willem Louw. The Council notes that Mr Katleho Lechoo, President of the ISRC subsequently retracted the utterances.
3. The Council strongly affirms its confidence in the relationship between the leadership of the UFS and the ISRC and expresses its appreciation for the University leadership’s commitment to continuously engage with students about matters of concern to them. The Council furthermore encourages positive and constructive engagement by the ISRC with the University leadership, as this contributes to shared-understanding of the challenges faced by the South African higher education sector and the governance of the UFS.
New research informs improved treatment of brain inflammation
2017-10-13
Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish
Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology.
Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.
Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs.
Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology